APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 75 filers reported holding APTINYX INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,193 | +104.8% | 27,973 | +154.3% | 0.00% | – |
| Q3 2022 | $4,000 | -76.5% | 11,000 | -64.4% | 0.00% | – |
| Q2 2022 | $17,000 | -85.1% | 30,900 | -38.5% | 0.00% | – |
| Q1 2022 | $114,000 | -37.7% | 50,240 | -26.3% | 0.00% | – |
| Q4 2021 | $183,000 | -26.8% | 68,173 | -36.2% | 0.00% | – |
| Q3 2021 | $250,000 | -32.6% | 106,809 | -18.5% | 0.00% | – |
| Q2 2021 | $371,000 | +401.4% | 131,042 | +430.5% | 0.00% | – |
| Q1 2021 | $74,000 | -81.5% | 24,700 | -78.6% | 0.00% | – |
| Q4 2020 | $400,000 | +247.8% | 115,536 | +319.5% | 0.00% | – |
| Q2 2020 | $115,000 | -55.1% | 27,541 | -62.5% | 0.00% | – |
| Q3 2019 | $256,000 | -23.8% | 73,355 | -27.1% | 0.00% | – |
| Q2 2019 | $336,000 | +57.7% | 100,680 | +91.4% | 0.00% | – |
| Q1 2019 | $213,000 | -94.4% | 52,606 | -77.2% | 0.00% | -100.0% |
| Q4 2018 | $3,814,000 | -58.1% | 230,584 | -26.6% | 0.00% | -50.0% |
| Q3 2018 | $9,093,000 | +296.6% | 314,005 | +231.1% | 0.00% | +300.0% |
| Q2 2018 | $2,293,000 | – | 94,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
| ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
| Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
| NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
| DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
| Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
| Orbimed Advisors | 538,500 | $300,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |